Nulax Oral Solution contains Lactulose 10 mg, a synthetic disaccharide used primarily as a laxative to treat chronic constipation and hepatic encephalopathy. Lactulose works by metabolizing in the colon into low molecular weight organic acids, which acidify the colonic contents and promote osmotic retention of water, thereby softening stools and facilitating bowel movements. Additionally, its acidifying effect decreases the absorption of ammonia in the gut, making it effective in reducing blood ammonia levels in patients with hepatic encephalopathy. Nulax Oral Solution is indicated for patients requiring gentle and effective relief from constipation or those managing hepatic encephalopathy symptoms. The solution is administered orally, with dosage individualized based on clinical response and patient tolerance. Common side effects include flatulence, abdominal discomfort, and diarrhea, which typically resolve with continued use or dosage adjustment. Caution is advised in patients with galactosemia or those requiring electrolyte monitoring, as excessive use may lead to electrolyte imbalance or dehydration. Nulax Oral Solution should be used under medical supervision, particularly in patients with diabetes or other metabolic disorders. It is contraindicated in cases of intestinal obstruction or acute surgical abdomen. Proper adherence to dosing instructions ensures optimal therapeutic outcomes.